Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in Chronic Pelvic Pain Secondary to Endometriosis
NCT05670353Phase 3Terminated
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in chronic pelvic pain (CPP), endometriosis, sponsored by Universidade de São Paulo. Started Jan 2023; status: terminated.
02
Drugs
cannabidiol
03
Conditions
chronic pelvic pain (CPP)endometriosis
Beyond the preview
Go deeper on NCT05670353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05670353.